Bioregulatory therapy for overactive bladder

Kuzmin I.V.

FGBOU VO Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia, Saint-Petersburg, Russia

This review is devoted to the pathogenetic basis and clinical results of the use of a new domestic innovative drug Vesusten, which is based on polypeptides made of animal bladder tissue, for the treatment of patients with overactive bladder. Data are given regarding the epidemiology, pathogenesis factors and current treatment methods. The mechanisms of peptide regulation of physiological processes in humans are also described. The basic principles of the use of bioregulatory peptides for therapeutic purposes. The results of preclinical and clinical studies of the drug Vesusten are discussed in detail.

Keywords

About the Authors

Corresponding author: I.V. Kuzmin – Ph.D., MD, professor of the Department of Urology of FGBOU VO Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia, Saint-Petersburg, Russia; e-mail: kuzminigor@mail.ru

Similar Articles